FrancophonIA/ELRC3.0 huggingface dataset:
English: The maximum daily dose for the immediate-release tablets is 1.1 mg three times a day and in case of the prolonged release tablets is 3.15 mg once a day.
Slovenian: Največji dnevni odmerek za tablete s takojšnjim sproščanjem znaša 1,1 mg trikrat na dan, za tablete s podaljšanim sproščanjem pa 3,15 mg enkrat na dan.
English: • Parkinson's disease, a progressive brain disorder that causes shaking, slow movement and muscle stiffness.
Slovenian: • Parkinsonove bolezni, tj. napredujoče okvare možganov, ki povzroča tresenje, upočasnjeno izvajanje gibov in otrdelost mišic.
English: Pramipexole stimulates the brain as dopamine would, so that patients can control their movement and have fewer of the symptoms of Parkinson's disease, such as shaking, stiffness and slowness of movement.
Slovenian: Pramipeksol stimulira možgane enako kot dopamin, tako da lahko bolniki spet nadzirajo svoje gibe in kažejo manj simptomov Parkinsonove bolezni, kot so tresenje, okorelost in upočasnjeno izvajanje gibov.
English: The active substance in Oprymea, pramipexole, is a dopamine agonist, which imitates the action of dopamine.
Slovenian: Zdravilna učinkovina v zdravilu Oprymea, pramipeksol, je dopaminski agonist, ki posnema delovanje dopamina.
English: Immediate-release tablets release the active substance into the body immediately, and prolonged-release tablets release it slowly over a few hours.
Slovenian: Iz tablet s takojšnjim sproščanjem se učinkovina v telo sprosti takoj, iz tablet s podaljšanim sproščanjem pa se sprošča več ur.
English: The way pramipexole works in restless-legs syndrome is not fully understood.
Slovenian: Način delovanja pri sindromu nemirnih nog ni v celoti znan.
English: The syndrome is thought to be caused by problems in the way dopamine works in the brain, which can be corrected by pramipexole.
Slovenian: Sindrom naj bi povzročila težava pri delovanju dopamina v možganih, ki jo je mogoče odpraviti s pramipeksolom.
English: Oprymea contains the active substance pramipexole.
Slovenian: Zdravilo Oprymea vsebuje učinkovino pramipeksol.
English: How does Oprymea work?
Slovenian: Kako zdravilo Oprymea deluje?
English: Therefore, the Agency's view was that, as for Sifrol, the benefit of Oprymea outweighs the identified risk and it can be authorised for use in the EU.
Slovenian: Zato je menila, da koristi zdravila Oprymea enako kot pri zdravilu Sifrol odtehtajo znana tveganja in da se zdravilo lahko odobri v EU.
English: How has Oprymea been studied?
Slovenian: Kako je bilo zdravilo Oprymea raziskano?
English: How is Oprymea used?
Slovenian: Kako se zdravilo Oprymea uporablja?
English: Oprymea can only be obtained with a prescription.
Slovenian: Predpisovanje in izdaja zdravila Oprymea je le na recept.
English: For Parkinson's disease, the starting dose is either one 0.088 mg immediate-release tablet three times a day or one 0.26 mg prolonged-release tablet once a day.
Slovenian: Pri Parkinsonovi bolezni je začetni odmerek ena 0,088-miligramska tableta s takojšnjim sproščanjem trikrat na dan ali ena 0,26-miligramska tableta s podaljšanim sproščanjem enkrat na dan. Odmerek je treba povečevati vsakih pet do sedem dni, dokler simptomi niso pod nadzorom, vendar zdravilo ne sme povzročiti nevzdržnih neželenih učinkov.
English: - are a young adult.
Slovenian: - ste mlajša odrasla oseba.
English: • an increased level of sugar in the blood
Slovenian: • zvišan nivo sladkorja v krvi
English: Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu.
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http://www.emea.europa.eu.
English: Using more than one of these medicines at the same time should be avoided.
Slovenian: Izgibati se moramo sočasni uporabi več kot enega od teh zdravil.
English: The therapeutic benefit should be reassessed regularly (at least every three months) (see Section 5.1).
Slovenian: Terapevtsko korist je treba redno ponovno ocenjevati (vsaj enkrat na vsake tri mesece) (glejte poglavje 5.1).
English: Children and adolescents There is no experience in children and adolescents (see section 4.4).
Slovenian: Otroci in mladostniki Izkušenj pri otrocih in mladostnikih ni (glejte poglavje 4.4).
English: • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities
Slovenian: • kadar imetnik dovoljenja za uporabo z zdravilom prejme nove informacije, ki lahko vplivajo na trenutne varnostne specifikacije zdravila, načrt farmakovigilance ali na dejavnosti za zmanjšanje tveganja,
English: Frequency estimate: Very common (≥1/10), common (≥1/100 and <1/10), uncommon (≥1/1,000 and <1/100), rare (≥ 1/10,000 and <1/1,000), very rare (<1/10,000), not known (cannot be estimated from the available data).
Slovenian: Preglednica 1: Neželeni učinki Ocene pogostnosti: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 in < 1/10), občasni (≥ 1/1.000 in < 1/100), redki (≥ 1/10.000 in < 1/1.000), zelo redki (< 1/10.000), ni znano (ocena iz danih podatkov ni možna).
English: De la Industria, 30,28108 Alcobendas, Madrid, Spain.
Slovenian: de la Industria, 30, 28108 Alcobendas, Madrid, Španija.
English: Therefore,in patients with known hypertension and/or other cardiac disease, blood pressure monitoring is recommended, especially during the first month of treatment.
Slovenian: Zato pri bolnikih z znano hipertenzijo in/ali drugim srčnim obolenjem priporočamo spremljanje krvnega tlaka, zlasti v prvem mesecu zdravljenja.
English: You may be more likely to think like this if you: - have previously had thoughts about killing or harming yourself.
Slovenian: Pojav takšnih misli je verjetnejši, če: - ste že kdaj razmišljali o samomoru ali samopoškodovanju.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 8th October 2008
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET 08. oktober 2008
English: • fast or irregular heart beat
Slovenian: • hitro ali nepravilno bitje srca
English: • tinnitus (perception of sound in the ear when there is no external sound)
Slovenian: • tinitus (zvonenje v ušesih, kljub temu da ni zunanjega zvoka)
English: There are no data on the use of duloxetine in pregnant women.
Slovenian: Podatkov o uporabi duloksetina pri nosečnicah ni.
English: Age: pharmacokinetic differences have been identified between younger and elderly females (≥65 years) (AUC increases by about 25% and half-life is about 25% longer in the elderly), although the magnitude of these changes is not sufficient to justify adjustments to the dose.
Slovenian: Starost: ugotavljali so farmakokinetične razlike med mlajšimi in starejšimi ženskami (≥ 65 let) (pri starejših se AUC poviša za približno 25 %, razpolovni čas pa je daljši za približno 25 %), vendar obseg teh sprememb ni tolikšen, da bi upravičil prilagajanje odmerka.
English: Suicidal ideation 5 Suicidal5
Slovenian: Razmišljanje o samomoru5
English: CNS medicinal products: the risk of using duloxetine in combination with other CNS-active medicinal products has not been systematically evaluated, except in the cases described in this section.
Slovenian: Zdravila CŽS: tveganja uporabe duloksetina v kombinaciji z drugimi zdravili, ki delujejo na CŽS, niso sistematično vrednotili, razen v primerih, opisanih v tem poglavju.
English: Hypertension Hypertensive crisis
Slovenian: Hipertenzija Hipertenzivna kriza
English: • serious allergic reaction which causes difficulty in breathing or dizziness or hives
Slovenian: • resne alergične reakcije, ki povzročajo težave pri dihanju, omotico ali izpuščaje
English: No studies on the effects on the ability to drive and use machines have been performed.
Slovenian: Študij vpliva na sposobnost vožnje in upravljanja s stroji niso izvedli.
English: Convulsion1
Slovenian: Konvulzije1
English: • sexual problems, including changes in ejaculation and abnormal orgasm
Slovenian: • težave s spolnostjo, vključno s spremembami v ejakulaciji, neobičajen orgazem
English: 3See section 4.4
Slovenian: 3Glejte poglavje 4.4.
English: For selective, reversible MAOIs, like moclobemide, the risk of serotonin syndrome is lower.
Slovenian: Pri selektivnih reverzibilnih MAOI, denimo moklobemidu, je tveganje za serotoninski sindrom manjše.
English: • abnormal periods, including heavy or prolonged periods
Slovenian: • neobičajna menstruacija, vključno z močno ali podaljšano menstruacijo
English: Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucroseisomaltase insufficiency should not take this medicine.
Slovenian: Bolniki z redko dedno intoleranco za fruktozo, malabsorpcijo glukoze/galaktoze ali pomanjkanjem saharoze-izomaltaze ne smejo jemati tega zdravila.
English: The MAH must ensure that the system of pharmacovigilance, as described in Edition 5.2 dated April 2009 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
Slovenian: Imetnik dovoljenja za promet mora zagotoviti, da je sistem farmakovigilance, kot je opisan v različici 5.2 iz aprila 2009 predstavljen v modulu 1.8.1 vloge za pridobitev dovoljenja za promet z zdravilom, vzpostavljen in deluje pred prihodom zdravila na trg in dokler bo zdravilo na tržišču.
English: • allergic reactions, increased tendency to bruise, blisters or sensitivity to sunlight
Slovenian: • alergične reakcije, povečano nagnjenje k modricam, mehurji ali občutljivost na sončno svetlobo
English: Very Rare Frequency not known
Slovenian: Pogostnost ni znana
English: Use with antidepressants
Slovenian: Sočasna uporaba z antidepresivi
English: 2Cases of orthostatic hypotension and syncope have been reported especially at the initiation of treatment.
Slovenian: 2O primerih ortostatske hipotenzije in sinkope so poročali zlasti ob začetku zdravljenja.
English: Oral anticoagulants: medicines which thin the blood.
Slovenian: Peroralni antikoagulanti: zdravila za redčenje krvi.
English: • large pupils (the dark centre of the eye), visual disturbance
Slovenian: • večje zenice (temni osrednji del očesa), motnja vida
English: • poor sleep quality
Slovenian: • slaba kvaliteta spanja
English: The elimination half-life of duloxetine ranges from 8 to 17 hours (mean of 12 hours).
Slovenian: Razpolovni čas izločanja duloksetina je od 8 do 17 ur (povprečno 12 ur).
English: Treatment of diabetic peripheral neuropathic pain in adults.
Slovenian: Zdravljenje bolečine diabetične periferne nevropatije pri odraslih.
English: Caution is required in patients at increased risk for hyponatremia; such as elderly, cirrhotic, or dehydrated patients or patients treated with diuretics.
Slovenian: Previdnost je potrebna pri bolnikih z večjim tveganjem za hiponatriemijo; denimo pri starejših, bolnikih s cirozo, dehidriranih bolnikih ali bolnikih, ki jemljejo diuretike.
English: These medicines increase the risk of side effects; if you get any unusual symptom taking any of these medicines together with DULOXETINE BOEHRINGER INGELHEIM, you should see your doctor.
Slovenian: Ta zdravila povečajo tveganje za neželene učinke; če se pojavi kakršenkoli neobičajen simptom ob jemanju katerega od teh zdravil skupaj z zdravilom DULOKSETIN BOEHRINGER INGELHEIM, obiščite svojega zdravnika.
English: Oral contraceptives and other steroidal agents: results of in vitro studies demonstrate that duloxetine does not induce the catalytic activity of CYP3A.
Slovenian: Peroralni kontraceptivi in druge steroidne učinkovine: rezultati študij in vitro kažejo, da duloksetin ne inducira katalitske aktivnosti CYP3A.
English: Limited data suggest that the plasma levels of duloxetine are higher in these patients.
Slovenian: Omejeni podatki kažejo, da so pri teh bolnikih plazemske koncentracije duloksetina višje.
English: 4Cases of aggression and anger have been reported particularly early in treatment of after treatment discontinuation.
Slovenian: 4O primerih agresije in jeze so poročali zlasti ob začetku zdravljenja in po prekinitvi zdravljenja.
English: Do not drive or use any tools or machines until you know how DULOXETINE BOEHRINGER INGELHEIM affects you.
Slovenian: Ne vozite in ne upravljajte z orodji ali stroji, dokler ne veste, kako zdravilo DULOKSETIN BOEHRINGER INGELHEIM vpliva na vas.
English: Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Slovenian: Jemanje drugih zdravil: Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
English: Abnormal dreams
Slovenian: Nenavadne sanje
English: Gender: pharmacokinetic differences have been identified between males and females (apparent plasma clearance is approximatively 50% lower in females).
Slovenian: Spol: med moškimi in ženskami so ugotovili farmakokinetične razlike (očitni plazemski očistek je pri ženskah približno 50 % nižji).
English: Angio-neurotic oedema StevensJohnson Syndrome
Slovenian: Angionevrotič ni edem StevensJohnsonov sindrom
English: Tachycardia Supraventricular arrhythmia, mainly atrial fibrillation
Slovenian: Tahikardija Supraventrikul arna aritmija, zlasti atrijska fibrilacija
English: Blood cholesterol increased
Slovenian: Zvišanje krvnega holesterola
English: • increased level of cholesterol in the blood, low levels of sodium in the blood (the symptoms are feeling sick and unwell with weak muscles or confused),
Slovenian: • zvišan nivi holesterola v krvi, nizka raven natrija v krvi (simptomi so slabost in slabo počutje z občutkom šibkosti mišic in zmedenostjo)
English: Excipients: sucrose 17.2 mg.
Slovenian: Pomožne snovi: saharoza 17,2 mg.
English: • problems getting an erection, less sex drive
Slovenian: • težave z erekcijo, manjša želja po spolnosti
English: Table 1 gives the adverse reactions observed from spontaneous reporting and in placebo-controlled clinical trials (comprising a total of 6828 patients, 4199 on duloxetine and 2629 on placebo).
Slovenian: Preglednica 1 prikazuje neželene učinke, ki so jih opažali v spontanih poročanjih in v s placebom kontroliranih kliničnih preskušanjih (skupno 6.828 bolnikov, 4.199 jih je jemalo duloksetin, 2.629 jih je dobilo placebo).
English: The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in Revision 0 of 24 April 2008 of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP.
Slovenian: Imetnik dovoljenja za promet z zdravilom se obvezuje, da bo izvedel študije in dodatne farmakovigilančne aktivnosti, podrobno opisane v načrtu farmakovigilance, sprejetem v različici 0 z dne 24. aprila 2008, načrta za obvadovanje tveganja (RMP), predstavljenem v modulu 1.8.2 vloge za pridobitev dovoljenja za promet z zdravilom in vseh nadaljnih posodobitvah RMP, s katerimi soglaša CHMP.
English: Polyvinylchloride (PVC), Polyethylene (PE), and Polychlorotrifluoroethylene (PCTFE) blister sealed with an aluminum foil.
Slovenian: Pretisni omot iz polivinilklorida (PVC), polietilena (PE) in poliklorotrifluoroetilena (PCTFE), zaprt z aluminijasto folijo.
English: Hepatic impairment: moderate liver disease (Child Pugh Class B) affected the pharmacokinetics of duloxetine.
Slovenian: Okvarjeno delovanje jeter: zmerno okvarjeno delovanje jeter (razred Child Pugh B) je vplivalo na farmakokinetiko duloksetina.
English: • increase in blood pressure, feeling cold in your fingers and/or toes, feeling dizzy (particularly when standing up too quickly), cold sweats, shivering or fainting
Slovenian: • zvišan krvni tlak, občutek mraza v prstih in/ali prstih na nogah, občutek omotičnosti (zlasti ob prehitrem vstajanju), hladen znoj, drgetanje ali omedlevica
English: Medicines that cause sleepiness: These include medicines prescribed by your doctor including benzodiazepines, strong painkillers, antipsychotics, phenobarbital, antihistamines.
Slovenian: Zdravila, ki povzročajo zaspanost: taka zdravila vam je predpisal vaš zdravnik, med njimi so, denimo, benzodiazepini, močna zdravila proti bolečinam, antipsihotiki, fenobarbital, antihistaminiki.
English: Both cytochromes P450-2D6 and 1A2 catalyse the formation of the two major metabolites glucuronide conjugate of 4-hydroxy duloxetine and sulphate conjugate of 5hydroxy,6-methoxy duloxetine.
Slovenian: Oba citokroma, P450-2D6 in 1A2, katalizirata tvorbo dveh poglavitnih presnovkov glukuronidnega konjugata 4-hidroksi duloksetina in sulfatnega konjugata 5-hidroksi 6-metoksi duloksetina.
English: Some patients who stop taking DULOXETINE BOEHRINGER INGELHEIM suddenly have had symptoms such as :
Slovenian: Nekateri bolniki, ki so nenadoma prenehali jemati zdravilo DULOKSETIN BOEHRINGER INGELHEIM, so imeli simptome, kot so:
English: Nursing mothers: The disposition of duloxetine was studied in 6 lactating women who were at least 12-weeks postpartum.
Slovenian: Doječe matere: Odlaganje duloksetina so preučevali pri 6 doječih ženskah v obdobju najmanj 12 tednov po porodu.
English: Cases of overdoses, alone or in combination with other medicinal products, with duloxetine doses of 5400mg were reported.
Slovenian: Poročali so o primerih prevelikega odmerjanja duloksetina samega ali v kombinaciji z drugimi zdravili, s 5400 mg odmerki duloksetina.
English: Tremor Paraesthesia
Slovenian: Tremor Parestezija
English: If your doctor has prescribed DULOXETINE BOEHRINGER INGELHEIM for a patient under 18 and you want to discuss this, please go back to your doctor.
Slovenian: Če je vaš zdravnik predpisal zdravilo DULOKSETIN BOEHRINGER INGELHEIM bolniku, mlajšemu od 18 let, in se želite o tem pogovoriti, se, prosimo, obrnite na svojega zdravnika.
English: • a sensation of restlessness or an inability to sit or stand still or “Serotonin syndrome” (a rare reaction which may cause feelings of great happiness, drowsiness, clumsiness, restlessness,
Slovenian: • občutek nemira ali nezmožnosti sedenja ali stanja pri miru ali “serotoninski sindrom” (redka reakcija, ki lahko povzroči občutke velike sreče, zaspanost, okornost, nemir, občutek pijanosti,
English: Talk to your doctor before you take the medicine if you:
Slovenian: Pred jemanjem zdravila se posvetujte s svojim zdravnikom, če:
English: Gastroenteritis Eructation Gastritis
Slovenian: Gastroenteritis Kolcanje Gastritis
English: Use in children and adolescents under 18 years of age No clinical trials have been conducted with duloxetine in paediatric populations.
Slovenian: Uporaba pri otrocih in mladostnikih, mlajših od 18 let Pri pediatričnih skupinah niso opravili kliničnih preskušanj z duloksetinom.
English: Although DULOXETINE BOEHRINGER INGELHEIM is not indicated for the treatment of depression, its active ingredient (duloxetine) also exists as an antidepressant medication.
Slovenian: Čeprav zdravilo DULOKSETIN BOEHRINGER INGELHEIM ni indicirano za zdravljenje depresije, njegova zdravilna učinkovina (duloksetin) obstaja tudi kot antidepresiv.
English: • feeling disorientated, feeling sleepy, lack of motivation
Slovenian: • zmedenost, zaspanost, pomanjkanje motivacije
English: Skin and Subcutaneous Tissue Disorders Sweating increased
Slovenian: Bolezni kože in podkožja Povečano znojenje
English: Taking a MAOI together with many prescription medicines, including DULOXETINE BOEHRINGER INGELHEIM, can cause serious or even life-threatening side effects.
Slovenian: Jemanje MAOI skupaj z mnogimi zdravili na recept, vključno z zdravilom DULOKSETIN BOEHRINGER INGELHEIM, lahko povzroči resne ali celo smrtno nevarne neželene učinke.
English: The usual dose of DULOXETINE BOEHRINGER INGELHEIM is 1 capsule (60 mg) once a day, but your doctor will prescribe the dose that is right for you.
Slovenian: Običajen odmerek zdravila DULOKSETIN BOEHRINGER INGELHEIM je 1 kapsula (60 mg) enkrat na dan, za vas ustrezen odmerek pa vam bo predpisal vaš zdravnik.
English: • inflammation of the liver that may cause abdominal pain
Slovenian: • vnetje jeter, ki lahko povzroči bolečine v trebuhu
English: • burping, indigestion, gastroenteritis
Slovenian: • riganje, slaba prebava, gastroenteritis
English: Libido decreased
Slovenian: Zmanjšanje libida
English: - are taking other medicines to treat depression(see ‘Taking other medicines') - are taking St. John's Wort, a herbal treatment (Hypericum perforatum) - have kidney disease - have had seizures (fits) - have had mania - suffer from bipolar disorder - have eye problems, such as certain kinds of glaucoma (increased pressure in the eye) - have a history of bleeding disorders (tendency to develop bruises) - are at risk of low sodium levels - are currently being treated with another medicine which may cause liver damage - are taking other medicines containing duloxetine - have intolerance to some sugars (see end of Section 2) - are considering stopping DULOXETINE BOEHRINGER INGELHEIM (see section 3)
Slovenian: - jemljete šentjanževko, pripravek rastlinskega izvora (Hypericum perforatum) - imate ledvično bolezen - imeli ste epileptične napade (krče) - ste imeli manijo - imate bipolarno motnjo - imate težave z očmi, denimo določene vrste glavkoma (zvišan tlak v očesu) - ste v preteklosti imeli motnje strjevanja krvi (nagnjenost k razvoju podplutb) - imate tveganje za nizek nivo natrija - se trenutno zdravite z drugimi zdravili, ki lahko povzročijo poškodbo jeter - jemljete druga zdravila, ki vsebujejo duloksetin - ne prenašate nekaterih sladkorjev (glejte konec poglavja 2) - premišljujete o prenehanju jemanja zdravila DULOKSETIN BOEHRINGER INGELHEIM
English: However, caution should be exercised when treating the elderly (see section 5.2).
Slovenian: Vendar pa je pri zdravljenju starejših potrebna previdnost (glejte poglavje 5.2).
English: DULOXETINE BOEHRINGER INGELHEIM should be used in pregnancy only if the potential benefit justifies the potential risk to the foetus.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM naj se v nosečnostu uporablja le, če možna korist upravičuje možno tveganje za plod.
English: DULOXETINE BOEHRINGER INGELHEIM increases the levels of serotonin and noradrenaline in the nervous system.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM zviša nivo serotonina in noradrenalina v živčnem sistemu.
English: You should use DULOXETINE BOEHRINGER INGELHEIM only after discussing the potential benefits and any potential risks to your unborn child with your doctor.
Slovenian: Zdravilo DULOKSETIN BOEHRINGER INGELHEIM lahko uporabljate le po tem, ko ste se o možnih koristih in morebitnih možnih tveganjih za vašega nerojenega otroka pogovorili s svojim zdravnikom.
English: The plasma concentration of duloxetine displays large inter-individual variability (see 5.2).
Slovenian: Plazemska koncentracija duloksetina izkazuje veliko različnost med posamezniki (glejte poglavje 5.2).
English: • yellow colouration of the skin (jaundice), hepatic failure, Stevens-Johnson syndrome, sudden swelling of skin or mucosa (angioedema)
Slovenian: • rumeno obarvanje kože (zlatenica), odpoved jeter, Stevens-Johnsonov sindrom, nenadna oteklina mukoze kože (angioedem)
English: • feeling the heart pumping in the chest, flushing, increased sweating, night sweats
Slovenian: • občutek bitja srca v prsih, zardevanje, povečano znojenje, nočno znojenje
English: Duloxetine is used under different trademarks in several indications (treatment of diabetic neuropathic pain, major depressive episodes as well as stress urinary incontinence).
Slovenian: Duloksetin uporabljamo za več indikacij z različnimi zaščitenimi imeni (zdravljenje bolečine pri diabetični nevropatiji, velike depresivne epizode in tudi stresne urinske inkontinence).
English: • tremor or numbness, including numbness or tingling of the skin
Slovenian: • tresenje ali otrplost, vključno z otrplostjo ali mravljinčasto kožo
English: (reported especially in diabetic patients)
Slovenian: Hiperglikemija (poročana zlasti pri diabetičnih bolnikih)